A Unique Human Immunoglobulin Heavy Chain Variable Domain-Only CD33 CAR for the Treatment of Acute Myeloid Leukemia

Acute myeloid leukemia (AML) remains a challenging pediatric and adult disease. Given the elevated expression of the CD33 antigen on leukemic blasts, therapeutic approaches to AML now feature the approved antibody drug conjugate (Mylotarg, GO) and investigational CART cell approaches incorporating C...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Dina, Xiong, Ying, Hu, Peirong, Wu, Darong, Chen, Weizao, Ying, Tianlei, Zhu, Zhongyu, Dimitrov, Dimiter S., Dropulic, Boro, Orentas, Rimas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262782/
https://www.ncbi.nlm.nih.gov/pubmed/30524966
http://dx.doi.org/10.3389/fonc.2018.00539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262782/
https://www.ncbi.nlm.nih.gov/pubmed/30524966
http://dx.doi.org/10.3389/fonc.2018.00539

Ejemplares similares